Invega is given as an intramuscular injection.

Invega (paliperidone palmitate) is administered via a single intramuscular injection, typically in the deltoid or gluteal muscle. Injection frequency varies - monthly, three-monthly, or six-monthly - depending on the dosage and individual patient needs. A healthcare professional must administer this medication.

Preparing for the Injection

  • Confirm Dosage: Verify the prescribed dosage with the patient's medical records.
  • Inspect Medication: Check the Invega suspension for particulate matter or discoloration.
  • Gather Supplies: Needle, syringe, alcohol swabs, and bandage.
  • Patient Positioning: Ensure the patient is comfortably positioned for easy access to the injection site.

Injection Procedure

  1. Cleanse Site: Thoroughly clean the injection site with an alcohol swab.
  2. Administer Injection: Inject the entire contents of the syringe slowly and deeply into the muscle.
  3. Remove Needle: Withdraw the needle at a 90-degree angle.
  4. Apply Pressure: Apply gentle pressure to the injection site with a sterile bandage.

Injection Site Rotation

Rotating injection sites is important to prevent tissue damage. Recommended sites include:

  • Left Deltoid
  • Right Deltoid
  • Left Gluteus Maximus
  • Right Gluteus Maximus

Invega Injection Schedules: A Comparison

Injection Frequency Dosage Range (Example) Typical Duration of Effect
Monthly 75mg - 150mg Approximately 4 weeks
Three-Monthly 200mg - 400mg Approximately 12 weeks
Six-Monthly 600mg - 800mg Approximately 24 weeks

Possible Side Effects

Common side effects include injection site pain, swelling, and redness. Serious side effects are rare but can occur. Report any unusual symptoms to a healthcare provider immediately.